TSE:4183
TSE:4183Chemicals

A Look at Mitsui Chemicals (TSE:4183) Valuation After Cutting Guidance on Lower Selling Prices and Restructuring

Mitsui Chemicals (TSE:4183) just updated its outlook for the full year, lowering its operating income forecast and indicating that sales revenue will fall short of earlier estimates. The company attributes this shift mainly to declining selling prices and the impact of business restructuring. See our latest analysis for Mitsui Chemicals. While Mitsui Chemicals’ updated outlook weighed on sentiment, the company’s recent stock split and steady dividend helped steady the mood. The share price...
TSE:4528
TSE:4528Pharmaceuticals

How Investors Are Reacting To Ono Pharmaceutical (TSE:4528) Winning Japanese Approval for New Braftovi Cancer Therapy

Ono Pharmaceutical recently received supplemental approval in Japan for Braftovi (encorafenib) capsule in combination with cetuximab and chemotherapy for treating unresectable, advanced, or recurrent colorectal cancer with BRAF mutation, following positive Phase III trial results. This milestone reflects Ono's ongoing progress in advancing new cancer therapies, supported by rigorous global clinical study data and regulatory recognition. We'll explore how regulatory progress in oncology,...
TSE:8050
TSE:8050Luxury

A Look at Seiko Group (TSE:8050) Valuation After Dividend Hike and New Earnings Outlook

Seiko Group (TSE:8050) just announced higher dividends for both the quarter and the full year, as well as updated earnings guidance for fiscal 2026. This signals stronger confidence from management in future performance. See our latest analysis for Seiko Group. Seiko Group’s steady confidence has clearly resonated with investors, as the share price has climbed 41.3% year-to-date and the one-year total shareholder return stands at a robust 67.8%. The company’s multi-year track record is even...
TSE:9719
TSE:9719IT

SCSK (TSE:9719): Assessing Valuation After a 32% Share Price Surge This Month

SCSK (TSE:9719) has caught the attention of investors following recent market activity. Over the past month, shares have climbed 32%. This has prompted questions about what may be behind the strong performance and how the stock is currently valued. See our latest analysis for SCSK. SCSK’s share price has climbed with a 31.8% gain over the past month and has more than doubled for shareholders in the past year. This suggests that momentum is building quickly as market optimism grows around the...
TSE:8750
TSE:8750Insurance

Will Dai-ichi Life’s Upgraded Earnings and Dividend Forecasts Change Its (TSE:8750) Investment Narrative?

Dai-ichi Life Holdings recently raised its consolidated earnings guidance and increased the year-end dividend forecast, citing stronger gains on securities sales due to robust stock prices and overall improved profitability for the period ending March 31, 2026. An important aspect is the company's expectation for higher net income and ordinary revenues, set against a backdrop of new share issuances and upcoming dividend payments, which signal changing priorities in capital management and...